(Q44891160)

English

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

Jacques Pirenne

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

8

object named as

Dirk Kuypers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Daan Dierickx

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Thomas Tousseyn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xavier Sagaert

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Steffen Fieuws

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Iwona Wlodarska

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Julie Morscio

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Lieselot Brepoels

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Johan Vanhaecke

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Frederik Nevens

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Geert Verleden

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Rita Van Damme-Lombaerts

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marleen Renard

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christiane De Wolf-Peeters

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Gregor Verhoef

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

9 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

2433-2440

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Treatment advances in posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

B cells under influence: transformation of B cells by Epstein–Barr virus

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Malignancies after heart transplantation: presence of Epstein-Barr virus and cytomegalovirus

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

EBV viral load detection in clinical virology

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.780655

21 January 2018

Identifiers

10.3109/10428194.2013.780655

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23442063%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44891160&oldid=1457924703"